Objective: To explore indirect evidence of reporting biases by examining the distribution of Pvalues reported in published medical articles, and to compare P-values distributions across different contexts.
What is new?
Key finding  There are discontinuities in the distributions of p-values from medical research studies at the typical thresholds of statistical significance that may provide indirect insights on reporting bias  Similar results were observed across various study designs and types.
What this study adds to what is known
 Notable peaks in the distributions at common thresholds of statistical significant are consistent with either suppression of non-statistically significant results or 'manipulation' of reported findings to reach statistical significance.  The outcome that is reported earliest in an article is more prone to this phenomenon than the primary outcome.
What is the implication, and what should change now?  The present investigation underpins the importance of the efforts and initiatives to tackle the mechanisms causing reporting biases (e.g. registration of studies, protocols and statistical analysis).  Researchers should continue to be encouraged to emphasize confidence intervals and effect sizes, rather than P-values, in the interpretation of results.  There is a need for advocating the importance of replication, as well as the benefits of complete publication of research findings to reduce the prevalence of reporting biases in scientific literature
Introduction
Complete publication of study results is essential to allow healthcare professionals and policy makers to make informed decisions. However, selective or distorted reporting is frequent in medical research. [1] Reporting biases arise if dissemination of research findings is influenced by the nature of the results. If undetected, reporting biases can lead to inaccurate conclusions and inappropriate decisions about health care and resource allocation, with potentially serious implications. [2] Failure to publish research findings honestly is unethical and a form of research misconduct. [3, 4] Furthermore, research inaccessibility leads to waste of limited resources, unnecessary duplication, and loss of trust in scientific integrity. [5] Reporting biases may impact scientific reports in different ways. [6] [7] [8] [9] First, a whole study may be suppressed, or harder to find, or published with delay, if its results are not considered to be interesting. The label 'publication bias' is typically used to refer to this phenomenon. [10] Publication bias is the form of reporting bias that has been most extensively discussed in the literature over the last 60 years. [11] [12] [13] Second, results within a report of a study may be biased if the authors report the most interesting findings. For example, they may report the finding with smallest P-value or largest effect estimate after performing several analyses on the same outcome. Several terms have been coined to refer to such practice, including selective analysis reporting, data dredging and p-hacking. [14] Alternatively, some outcomes that were measured and analysed may be missing if the authors did not consider the results to be interesting.
Although these reporting biases are likely to have been always present in the dissemination of research findings, more attention has been drawn to them recently due to the widespread use of systematic reviews. The validity of conclusions drawn from systematic reviews, intended to summarize the state of the art in a scientific area, is threatened if published results are not representative of the population of all conducted studies and analyses. Metaanalysis provides researchers with several graphical methods and statistical tests to assess the possible presence of reporting biases. [6, 10, 13, 15] The exponential growth of published meta-analyses, many of them including some assessment of reporting biases, is likely to have increased the concern of incomplete publication of results as an ubiquitous problem in the scientific literature. [8] Evidence of reporting biases can be direct or indirect. cross-sectional studies, and we considered a wide range of estimates including differences in means, risk ratios, odds ratios, hazard ratios, correlations and regression coefficients. We included only articles that either reported the P-value or provided sufficient information to calculate a P-value for either the first reported or the primary outcome. We excluded duplicate reports of the same study as well as inaccessible full-text articles (e.g. published abstracts without full articles, or study protocols).
Data screening and extraction
We developed a standardised data extraction form, which was pilot-tested by all members of the research team. We extracted data based on the first reported outcome in the abstract (preferentially) or in the results section. For each included article, we extracted the following information:
 Author list and citation details.
 Medical speciality: we used the categories suggested by Davey et al. [20]  Study type: therapeutic/intervention, prognostic, aetiological/risk factor.
 Study design: we used the classification used by Grimes et al: [21] randomized controlled trial (RCT), non-RCT, cohort, case-control, cross-sectional.
 Sample size: total sample size used in the analysis which yielded the P-value.
 Whether the primary outcome was specified (we considered the primary outcome to be specified if the authors had explicitly stated/labelled the primary outcome in the published report) (Yes/No) and whether it was the same as the first reported outcome (Yes/No/Unclear).
 2-sided P-value, or information sufficient to calculate it, for the first reported outcome and for the primary outcome (if specified). We used the following hierarchy to determine each P-value, where only one of the following types of information was required:
1. Exact 2-sided P-value: from the hypothesis test. Where a specified primary outcome differed from the first reported one, we implemented the same hierarchy to extract a P-value for each of the two outcomes.
Data analysis
As a first step, we transformed the two-sided p-values into absolute z-scores, and used the latter as our main dependent variable. We plotted the distribution of z-scores across all included studied, both for first reported outcomes and for primary outcomes, using histograms. In the absence of any bias and if all effects are truly null, these scores would have a standard half normal distribution. In the presence of genuine effects in some (or all) studies, we would expect the distribution to be shifted to the right and no longer half normal.
Furthermore, in the absence of reporting biases the distribution should be free of sharp discontinuities.
We repeated these plots with subsets of the studies to explore the distributions of z-scores stratified by medical specialty, study design and study type. Moreover, we used the caliper test described by Gerber and Malhotra to explore the existence of discontinuities in the distribution of z-scores around the critical values of 1.96 and 2.576 [19] . We compared the frequency of values in equal sized intervals just below and just above the threshold values commonly used for statistical significance (0.01 and 0.05) for first reported and primary outcomes, using a chi-squared test. We performed all analyses using the R statistical software (version 3.2.3). [23] Results
Description of included studies Figure 1 displays the study selection process in a flow chart. Of the 1500 randomly selected articles, we included 758 (50.5%). Among these included articles, 422 (56%) described therapeutic/intervention studies, 207 (27%) were aetiological/risk factor studies, and 129 (17%) were prognostic studies. With regards to study design, 264 (35%) were RCTs, 53 (7%)
were non-RCTs, 145 (19%) were cross-sectional, 238 (32%) were cohort and 55 (7%) were case-control studies.
The medical disciplines of the included articles were cancer (N=105; 14%), cardiovascular (N=116; 15%), central nervous system/musculoskeletal (N=97; 13%), digestive, endocrine, nutritional and metabolic (N=98; 13%), gynaecology/pregnancy/birth (N=58; 8%), infectious (N=44; 6%), mental health/behavioural (N=75; 10%), urogenital (N=33; 4%), respiratory (N=21; 3%) and other disorders (N=111; 14%). The sample size of all included studies ranged from 6 to 375,888, with a median of 142 participants (range 55-525; IQR=470).
Out of the 264 included RCTs, the primary outcome was specified in 190 (72%). The primary outcome was also the first reported outcome in 143 (75%) studies, while it was not the first reported outcome in 45 (24%) and unclear in 2 (1%). In studies other than RCTs, the primary outcome was specified only in 199 out of 494 included studies (40%). The primary outcome was also the first reported outcome in 133 (67%) studies, while it was not the first reported outcome in 65 (33%) and unclear in one study.
The 742 excluded articles comprised 245 (33%) with only descriptive statistics, 144 (19%) with no original data, 121 (16%) with inaccessible full texts, 84 (11%) that were diagnostic or costanalysis studies, 58 (8%) without sufficient information to extract or calculate a P-value, 48
(7%) with non-human research participants and 42 (6%) that were qualitative.
Empirical distribution of z-scores and p-values
We retrieved 758 results for first reported outcomes, with a median P-value of 0.011 and Pvalues of 0.0006 and 0.045 for the first and third quartiles, respectively. Figure 2 shows the distribution of z-scores for first reported outcomes and primary outcomes, with dashed vertical lines for the common thresholds of z = 1.96 and z = 2.576 (corresponding to p = 0.05 and p = 0.01, respectively) for statistical significance. In both distributions, there is a clear majority of z-scores above the threshold levels. Of particular note is the dramatic spike in the frequency of z-scores just over the significance threshold z-score of 1.96 and 2.576. The results of the caliper tests using 5% and 10% caliper sizes for the first reported outcomes as well as primary outcomes showed a notable imbalance in the numbers of findings around the common significance threshold of 1.96 (P-value = 0.05), which is evident across the two caliper sizes (5% and 10%) in both first reported outcomes and primary outcomes (Table 1) .
When using a significance threshold of 2.576, there was also a significant inbalance in the number of findings for both first reported and primary outcomes using the 5% caliper size, but not using the 10% size. Table 2 shows that the majority of the retrieved P-values (both for first reported and primary outcomes) were smaller than common significance thresholds (0.05 and 0.01) with a total of 592 (78%) P-values of first reported outcomes were equal to or smaller than 0.05, and 376 (50%) were also equal to or smaller than 0.01.
The distribution of P-values reported in included studies for the first reported outcomes compared with the primary outcomes and grouped by study design (RCTs vs. studies other than RCTs). It shows that P-values more likely to be significant for the first reported outcomes than for the primary outcomes in RCTs only (p-value = 0.02391) ( Table 3) . Figure 3 shows the histograms of z-scores for first reported outcomes stratified by medical speciality, annotated by median sample sizes within specialties. All figures reflect the same pattern of a majority of z-scores over the threshold of statistical significance, but the distributions appear less skewed in some of the disciplines with larger average sample sizes, namely infectious diseases (N=28; 63.6% of z-scores above 1.96), urogenital (N=21; 63.6%) and cancer (N=75; 71.4%). The most extreme patterns appeared in the area of respiratory diseases (N=19; 90.5% of z-scores above 1.96), cardiovascular (N=97; 83.6%) and central nervous system or musculoskeletal disorders (N=78; 80.4%). Similar trends were observed in the histograms of z-scores for primary outcomes stratified by medical speciality, which are provided in Appendix 2.
Stratified analyses
Histograms of z-scores for first reported outcomes did not show major differences in the distribution according to study design (Figure 4 ). Likewise, we obtained similar histograms when exploring the distributions of z-scores for first reported outcomes stratified by study type, and also when plotting the distributions of z-scores for primary outcomes stratified by study design or by study type (Appendix 2).
Discussion
Our distributions of reported P-values from medical research studies show notable peaks (or discontinuities) in the distributions at the common thresholds of statistical significance (p = 0.05 and p = 0.01) that may provide indirect insights on reporting bias. The outcome that is reported earliest in an article is more prone to this phenomenon than the primary outcome.
Only about half of the included articles specified the primary outcome, and in 28% of the articles the first reported outcome was not the primary outcome. Similar patterns were observed across various medical discplines, study designs and types.
Strengths of our study include use of a large random sample of 1500 articles recently published, of which 758 contributed to the analysis. We also implemented manual data extraction from the articles; provided a breakdown by medical disciplines, study type and study design; and computed P-values when they were not reported directly. However, we
were unable to retrieve all of the articles listed in our random sample (see Figure 1) . We are unable to draw any conclusions about whether the observed distribution is due to data manipulation ('p-hacking') or genuine effects, because as Bruns and Ioannidis suggested [24] , p-curves may neither identify genuine effects nor p-hacking in observational research.
The presence of reporting biases has been claimed repeatedly in the medical literature, [1, 4, 8] and in other areas as diverse as cognitive sciences, [17, 25] biology, [26] educational research, [27] political sciences, [28] and management research. [7] Although definitions of reporting biases and strategies to explore vary, the conclusions and implications for researchers are similar across disciplines. Previous studies have investigated empirical distributions of published P-values. A study of abstracts in PubMed reported an extremely skewed distribution of P-values, with a substantially higher proportion of P-values below 0.05 in non-randomized studies compared to randomized trials. [29] In a review of meta-analyses, Ioannidis and Trikalinos also concluded that significant P-values were overrepresented [30] . In psychology, some studies also explored the P-value distribution and showed an inordinately high number of P-values just below 0.05. [17, 31] It is good practice to specify the primary outcome before performing the statistical analysis of a clinical trial. [9] In our survey, we found that 72% of the RCTs vs. 40% of studies other than RCTs specified the primary outcome in their reports. Moreover, the specified primary outcome and first reported outcome differed in 24% of the included RCTs compared with 33% in the included studies other than RCTs. In addition, we found that the proportion of significant P-values is higher in first reported outcomes compared with primary outcomes in
RCTs. This is consistent with observations in epidemiological research comparing primary outcomes stated in the protocol with those declared in the final report. [32, 33] Reporting biases are a prevalent and complex phenomenon across most scientific areas, including epidemiology. Our survey adds to the evidence that statistically significant findings are still overrepresented in current medical research. The phenomenon limits the validity of conclusions drawn from the published literature, and has led to expressions of major concerns and disbelief about the usefulness of scientific evidence. [34, 35] It is important that techniques are used to assess the potential extent of these threats to published evidence, whether in the context of a systematic review or otherwise. Meta-analysis methods provide some of the most direct tools for this, although have major limitations.
Efforts should be increased to tackle the mechanisms causing reporting biases. Initiatives to facilitate registration of studies, protocols and statistical analysis plans are key in this regard.
The common practice of interpreting results based on significance tests is likely to have an important role, and researchers should continue to be encouraged to emphasize confidence intervals and effect sizes, rather than P-values, in the interpretation of results. [22, 36, 37] Furthermore, the pressure imposed on researchers to produce scientific publications on a regular basis, coupled with the increasing emphasis on research impact (including journal impact factor), may lead them to dismiss scientific findings for publication if their results are insufficiently innovative or not in agreement with the dominant paradigm. This risks a prioritization of aspects other than rigor and scientific quality when presenting their findings in scientific reports. [38] A new framework in which the importance of replication, as well as the benefits of complete publication of research findings, has been advocated as a promising approach to reduce the prevalence of reporting biases in scientific literature. [25, 39, 40] Tables 
